Skip to main content Skip to page footer

Squamous cell carcinoma

Logo des NCT Heidelberg Logo des NCT Heidelberg

Squamous cell carcinoma

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Cutaneous Squamous Cell Carcinoma Patients Progressing on or Intolerant to Systemic Treatment.
Phase: II
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT07228442
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2025-523231-19-00

Title: A Phase I Study to Evaluate Safety and Early Signs of Efficacy of the Human Monoclonal Antibody-cytokine Fusion Protein IL12-L19L19.
Phase: I
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04471987
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

Title: IMPULS-A: Implementierung eines Unterstützungsprogramms für Langzeitkrebsüberlebende im Alter
Phase: N/A
Contact: M. Sc. Charlotte Flock / Kontaktperson
Email-Address: IMPULS-A(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Hans-Christoph Friederich
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: Randomized Comparison of Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Patients With Advanced Rare Cancers (RATIONALE)
Phase: N/A
Contact: Elke Bauriegel / Kontaktperson
Email-Address: rationale_pm(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06855134
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: NCT MASTER Plattform Molecularly Aided Stratification for Tumor Eradication Research
Phase: N/A
Contact: MASTER Studienbüro / Kontaktperson
Email-Address: master(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Stefan Fröhling
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05852522
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: